Expression of Metastatic Tumor Antigen 1 Splice Variant Correlates With Early Recurrence and Aggressive Features of Hepatitis B Virus-Associated Hepatocellular Carcinoma

Hepatology : Official Journal of the American Association for the Study of Liver Diseases
Yung-Tsung LiChun-Jen Liu

Abstract

Overexpression of metastatic tumor antigen 1 (MTA1) was correlated with poor prognosis of hepatitis B virus (HBV)-associated hepatocellular carcinoma (HBV-HCC). The aim of this study was to examine the clinical significance of the expression of MTA1 and its exon 4-excluded form (MTA1dE4), the most abundant spliced variant of MTA1, in patients receiving curative resection for HBV-HCC. We collected 102 patients with HBV-HCC and received curative resection retrospectively and examined the expressions level of total MTA1/MTA1dE4 in their paired nontumor and tumor liver tissues by using RT-qPCR. The association between MTA1/MTA1dE4 expression and various tumor features as well as tumor recurrence was analyzed. During the median follow-up period of 4 years, 25 patients (24.5%) showed early recurrence (within 12 months postresection) and 42 (54.5%) showed late recurrence. In Kaplan-Meier analysis, MTA1dE4 overexpression in tumor, but not MTA1, was associated with early recurrence (P = 0.0365), but not late recurrence. In multivariate analysis, only alpha-fetoprotein (AFP) ≥200 ng/mL (P = 0.006) and large tumor size (P = 0.027) were correlated with early recurrence. In the subgroup of patients with AFP <200 ng/mL, high MTA1dE4, but not...Continue Reading

References

Dec 1, 1992·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·S C JwoW Y Lui
Oct 5, 2001·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·J H KaoD S Chen
Apr 10, 2007·The International Journal of Biochemistry & Cell Biology·Rolf I Skotheim, Matthias Nees
Jul 10, 2007·Journal of the American College of Surgeons·Hauke LangChristoph E Broelsch
Feb 29, 2008·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Soo Hyung RyuKyu-Won Kim
Jul 22, 2008·World Journal of Surgery·Kazuhiro KondoJiro Ohuchida
Sep 15, 2009·Journal of Hepatology·Jaw-Ching WuWing-Yiu Lui
Apr 27, 2012·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Edoardo G GianniniUNKNOWN Italian Liver Cancer (ITA.LI.CA) group
Nov 23, 2013·Molecular Carcinogenesis·Sachin Raj M NagarajBharathi P Salimath
Sep 19, 2014·World Journal of Gastroenterology : WJG·Su Jong Yu, Yoon Jun Kim
Oct 27, 2014·Cancer Metastasis Reviews·Nirmalya SenRakesh Kumar
Oct 30, 2014·Cancer Metastasis Reviews·Christopher J MillardJohn W R Schwabe
Jun 22, 2015·Advances in Cancer Research·Da-Qiang Li, Rakesh Kumar

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cell Migration in Cancer and Metastasis

Migration of cancer cells into surrounding tissue and the vasculature is an initial step in tumor metastasis. Discover the latest research on cell migration in cancer and metastasis here.

Cell Migration

Cell migration is involved in a variety of physiological and pathological processes such as embryonic development, cancer metastasis, blood vessel formation and remoulding, tissue regeneration, immune surveillance and inflammation. Here is the latest research.